ArticleNPJ precision oncology2026

AI-driven virtual screening platform identifies novel NSUN2 inhibitor candidates for targeted cancer therapy: a computational drug discovery approach.

Shuangqi Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.